ENDOBARIHEART STUDY

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMaria Cecilia Hospital

About this trial

The primary outcome of this study is to evaluate changes in cardiovascular risk after endoscopic sleeve gastroplasty (ESG) in patients at high cardiovascular risk, using the SCORE2 ( Systematic COronary Risk Evaluation 2) and SCORE2-OP ( Systematic COronary Risk Evaluation 2 Older Persons) risk scores, which estimate the risk of having a cardiovascular event.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

informed consent

obesity or overweight

atherosclerotic cardiovascular disease

type 1 or type 2 diabetes mellitus

Disqualifiers

chronic inflammatory diseases

active viral or bacterial infections

severe anaemia or severe coagulopathy

severe chronic kidney failure

Trial design

Design model

Single group

Treatments tested in this trial

  • echocardiography

    Other intervention

    Echocardiography will be performed in each patient The following parameters will be assessed: systolic function, diastolic function, presence/absence of ventricular hypertrophy, left atrial volume indexed (LAVi), left atrial strain (LAS), valvular morphology and function, estimated intracardiac pressures

  • Coronary CT angiography

    Radiation

    Coronary CT angiography has a duration of 10-15 minutes per patient and requires the use of contrast

  • blood analysis

    Biological/Vaccine

    Blood count, liver and kidney function, coagulation assessment, C-reactive protein, glycaemic and lipidic profile

Treatment groups

50 Participants
are divided into 1 treatment group
Group A: Patients Undergoing Endoscopic Sleeve GastroplastyOther 3 interventions

Trial outcomes

Primary outcomes

1

Changes in Systematic Coronary Risk Evaluation 2 ( SCORE 2) and Systematic Coronary Risk Evaluation 2 Older Persons (SCORE 2 OP) using algorithms after endoscopic sleeve gastroplasty.

Time frame
From enrollment to the end of follow up at 12 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: